These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3500002)

  • 1. An immunomodulating anti-rheumatic drug, lobenzarit disodium (CCA): inhibition of polyclonal B-cell activation and prevention of autoimmune disease in MRL/Mp-lpr/lpr mice.
    Mihara M; Nakano T; Ohsugi Y
    Clin Immunol Immunopathol; 1987 Dec; 45(3):366-74. PubMed ID: 3500002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term administration of cyclophosphamide in MRL/1 mice. I. The effects on the development of immunological abnormalities and lupus nephritis.
    Shiraki M; Fujiwara M; Tomura S
    Clin Exp Immunol; 1984 Feb; 55(2):333-9. PubMed ID: 6607792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of in vitro anti-DNA antibody production by a novel disease modifying anti-rheumatic drug, Lobenzarit.
    Hirohata S
    Clin Exp Rheumatol; 1992; 10(4):357-63. PubMed ID: 1356678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel antifolate, MX-68, inhibits the development of autoimmune disease in MRL/lpr mice.
    Mihara M; Takagi N; Urakawa K; Moriya Y; Takeda Y
    Int Arch Allergy Immunol; 1997 Aug; 113(4):454-9. PubMed ID: 9250591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of B cell function by lobenzarit, a novel disease-modifying antirheumatic drug.
    Hirohata S; Shinohara S; Inoue T; Miyamoto T; Lipsky PE
    Arthritis Rheum; 1992 Feb; 35(2):168-75. PubMed ID: 1734906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulating effect of a traditional Japanese medicine, hachimi-jio-gan (ba-wei-di-huang-wan), on Th1 predominance in autoimmune MRL/MP-lpr/lpr mice.
    Furuya Y; Kawakita T; Nomoto K
    Int Immunopharmacol; 2001 Mar; 1(3):551-9. PubMed ID: 11367538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of lupus dermatoses in autoimmune mice. XIX. Attempts to induce subepidermal immunoglobulin deposition in MRL/Mp- +/+ mice.
    Furukawa F; Ohshio G; Imamura S
    Arch Dermatol Res; 1993; 285(1-2):20-6. PubMed ID: 8470930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of several kinds of drugs on the development of autoimmunity in MRL/Mp-lpr/lpr mice; lack of correlation between the suppression of autoantibody production and prevention of autoimmune disease.
    Mihara M; Ohsugi Y
    J Pharmacobiodyn; 1989 Feb; 12(2):100-6. PubMed ID: 2526211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the role of the lpr gene in the development of immunological abnormalities and lupus nephritis. Analyses in F2 mice.
    Fujiwara M; Kariyone A; Shiraki M
    Clin Exp Immunol; 1985 Jan; 59(1):161-8. PubMed ID: 3918816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr mice.
    Jabs DA; Kuppers RC; Saboori AM; Burek CL; Enger C; Lee B; Prendergast RA
    Cell Immunol; 1994 Mar; 154(1):66-76. PubMed ID: 7907009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin.
    Fan JL; Himeno K; Tsuru S; Nomoto K
    Clin Exp Immunol; 1987 Oct; 70(1):94-101. PubMed ID: 3500817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of corticosteroid and 1,24R-dihydroxy-vitamin D3 administration on lymphoproliferation and autoimmune disease in MRL/MP-lpr/lpr mice.
    Koizumi T; Nakao Y; Matsui T; Nakagawa T; Matsuda S; Komoriya K; Kanai Y; Fujita T
    Int Arch Allergy Appl Immunol; 1985; 77(4):396-404. PubMed ID: 3874829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with 5,5-diphenylhydantoin reduces lymphadenopathy and anti-ssDNA autoantibodies in C57BL/6-lpr/lpr mice.
    Bloksma N; de Bakker JM; van Rooijen HJ; Punt P; Seinen W; Kammüller ME
    Int J Immunopharmacol; 1994 Mar; 16(3):261-8. PubMed ID: 8206693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked acceleration of the autoimmune disease in MRL-lpr/lpr mice by the influence of the Yaa gene from BXSB mice.
    Miyawaki S; Nakamura Y; Takeshita T; Yoshida H; Shibata Y; Mitsuoka S
    Lab Anim Sci; 1988 Jun; 38(3):266-72. PubMed ID: 2970562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment of autoimmune MRL/MP-lpr/lpr mice with a herbal medicine, Ren-shen-yang-rong-tang (Japanese name: Ninjin-youei-to) plus suboptimal dosage of prednisolone.
    Zhou NN; Nakai S; Kawakita T; Oka M; Nagasawa H; Himeno K; Nomoto K
    Int J Immunopharmacol; 1994 Oct; 16(10):845-54. PubMed ID: 7843856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice].
    Kobayashi K; Hamano T; Kakishita E
    Ryumachi; 1996 Dec; 36(6):844-55. PubMed ID: 9122824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice.
    Yan SX; Deng XM; Wang QT; Sun XJ; Wei W
    Acta Pharmacol Sin; 2015 Nov; 36(11):1367-76. PubMed ID: 26456588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn).
    Takahashi T; Yagi T; Kakinuma S; Kurokawa A; Okada T; Takatsu K; Aizawa S; Katagiri T
    J Immunol; 1997 Sep; 159(5):2532-41. PubMed ID: 9278347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT).
    Karussis DM; Vourka-Karussis U; Lehmann D; Abramsky O; Ben-Nun A; Slavin S
    Clin Exp Immunol; 1995 Apr; 100(1):111-7. PubMed ID: 7697909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B.
    Watanabe H; Garnier G; Circolo A; Wetsel RA; Ruiz P; Holers VM; Boackle SA; Colten HR; Gilkeson GS
    J Immunol; 2000 Jan; 164(2):786-94. PubMed ID: 10623824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.